To assess whether Trp53 null tumors require sustained Pdgfra overexpression, we isolated primary tumor cells from GBM-bearing p53ΔNmice and induced stable knockdown of Pdgfra using shRNA (Figure 3—figure supplement 5). The gene discussed is PDGFRA; the disease is glioblastoma.